REXO1L3P

Q-omics provides the consensus-scored REXO1L3P profile across patient tissues and cancer cell-line models. REXO1L3P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, REXO1L3P RNA expression shows 852 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where REXO1L3P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes REXO1L3P survival associations across molecular data types. REXO1L3P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

REXO1L3P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	KIRC (36)	view →

This table ranks reproducible REXO1L3P RNA expression–survival associations across cancer types. High REXO1L3P expression shows unfavorable associations in KIRC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .007). Together, the overview and detailed table identify KIRC as the clearest survival context for REXO1L3P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.236	0.805	.007	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

REXO1L3P-KIRC (OS)

Explore this curve interactively →